News Focus
News Focus
Followers 23
Posts 5144
Boards Moderated 0
Alias Born 06/24/2006

Re: randychub post# 1476

Friday, 07/27/2007 11:34:07 PM

Friday, July 27, 2007 11:34:07 PM

Post# of 3757
Clinical data to date shows Viread as better HBV drug than Hepsera...

Will Viread work better in monotherapy than Tyzeka... that is undetermined

All indications are GILD will promote Viread if / when approved.

Viread is a Nt
the approved Ns competitors - Baraclude and Tyzeka (telbivudine)

keep in mind telbivudine is the new kid on the block... as more clinical data becomes available... the picture will become clearer for telbivudine... Idenix is doing a head to head trials vs both Viread and Baraclude


The creation of a thousand forests is in one acorn.